Document is current
Any future updates will be listed below
-
Authors
Crandall, Henry
Schuessler, Tyler
Bělík, Filip https://orcid.org/0009-0004-0500-7583
Fabregas, Albert https://orcid.org/0009-0009-4222-9261
Stults, Barry M.
Boyadzhiev, Alexandra
Zhang, Huanan
Wu, Jim S.
Rodan, Aylin R. https://orcid.org/0000-0001-9202-2378
Juraschek, Stephen P. https://orcid.org/0000-0003-4168-2696
Mukkamala, Ramakrishna https://orcid.org/0000-0001-8918-4050
Cheung, Alfred K.
Drakos, Stavros G. https://orcid.org/0000-0002-1223-327X
Hohenegger, Christel
Osting, Braxton
Sanchez, Benjamin https://orcid.org/0000-0002-1594-9847
-
Funding
Funding for this research was provided by:
National Science Foundation (2139322)
National Science Foundation (2136198)
National Science Foundation (2529648)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R21CA273984- 01A1)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1P01CA285249-01A1)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R21CA289101-01A1)
U.S. Department of Health & Human Services | NIH | National Institute on Minority Health and Health Disparities (1R21MD018488-01A1)
B-Secur, Ltd
- License Information
-
More Information
Article History
Received: 4 September 2025
Accepted: 21 April 2026
First Online: 14 May 2026
Competing interests
: B.S. is a co-founder of and holds equity in Haystack Diagnostics, Inc. He holds equity and serves as Scientific Advisor to B-Secur, Ltd., and Sobr Safe, Inc. He holds equity and serves as a Chief Scientific Officer of Hemodynamiq, Inc. He serves as a Chief Scientific Advisor to First Capital Ventures, LLC, and Chief Scientific Officer to Promptus, LLC. He holds equity and serves as Head of Biosensing and Product Development of NeuralPoint AI, Inc. The other authors have no conflicts of interest to declare.
